PedAM
Pediatric Disease Annotations & Medicines
| Disease | hematopoietic stem cell transplantation |
| Phenotype | C0376545|hematologic neoplasms |
| Sentences | 1 |
| PubMedID- 26550118 | Objectives: the aim of the article is to critically appraise and synthesize available evidence regarding the efficacy and regimen-related toxicity (rrt) of busulfan plus fludarabine (buflu) compared to busulfan plus cyclophosphamide (bucy) as a conditioning regimen, prior to allogeneic hematopoietic stem cell transplantation (hsct) in patients with hematologic neoplasms. |
Page: 1